| Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design C Sánchez-Lafuente, S Furlanetto, M Fernández-Arévalo, ... International journal of pharmaceutics 237 (1-2), 107-118, 2002 | 104 | 2002 |
| Synthesis of lidocaine-loaded PLGA microparticles by flow focusing: effects on drug loading and release properties MA Holgado, JL Arias, MJ Cózar, J Alvarez-Fuentes, AM Gañán-Calvo, ... International journal of pharmaceutics 358 (1-2), 27-35, 2008 | 101 | 2008 |
| Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers C Sanchez-Lafuente, MT Faucci, M Fernández-Arévalo, ... International Journal of Pharmaceutics 234 (1-2), 213-221, 2002 | 101 | 2002 |
| Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies L Martín-Banderas, J Álvarez-Fuentes, M Durán-Lobato, J Prados, ... International journal of nanomedicine, 5793-5806, 2012 | 85 | 2012 |
| Diclofenac salts. I. Fractal and thermal analysis of sodium and potassium diclofenac salts A Fini, M Garuti, G Fazio, J Alvarez‐Fuentes, MA Holgado Journal of pharmaceutical sciences 90 (12), 2049-2057, 2001 | 75 | 2001 |
| Development of enteric-coated timed-release matrix tablets for colon targeting J Alvarez-Fuentes, M Fernández-Arévalo, ML González-Rodríguez, ... Journal of drug targeting 12 (9-10), 607-612, 2004 | 73 | 2004 |
| In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy L Martin-Banderas, I Muñoz-Rubio, J Prados, J Álvarez-Fuentes, ... International Journal of Pharmaceutics 487 (1-2), 205-212, 2015 | 67 | 2015 |
| Evaluation of Eudragit® RS-PO and Ethocel® 100 matrices for the controlled release of lobenzarit disodium A Boza, I Caraballo, J Alvarez-Fuentes, AM Rabasco Drug development and industrial pharmacy 25 (2), 229-233, 1999 | 61 | 1999 |
| Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules M A Holgado, L Martin-Banderas, J Alvarez-Fuentes, ... Current medicinal chemistry 19 (19), 3188-3195, 2012 | 53 | 2012 |
| Nanostructures for drug delivery to the brain L Martin-Banderas, M a Holgado, J L Venero, J Alvarez-Fuentes, ... Current Medicinal Chemistry 18 (34), 5303-5321, 2011 | 52 | 2011 |
| Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly (lactic-co-glycolic acid) nanoparticles M Durán-Lobato, I Muñoz-Rubio, M Holgado, J Álvarez-Fuentes, ... Journal of biomedical nanotechnology 10 (6), 1068-1079, 2014 | 50 | 2014 |
| Functional PLGA NPs for oral drug delivery: recent strategies and developments L Martin-Banderas, M Duran-Lobato, I Munoz-Rubio, J Alvarez-Fuentes, ... Mini reviews in medicinal chemistry 13 (1), 58-69, 2013 | 45 | 2013 |
| Insulin-loaded PLGA microparticles: flow focusing versus double emulsion/solvent evaporation MJ Cózar-Bernal, MA Holgado, JL Arias, I Muñoz-Rubio, ... Journal of Microencapsulation 28 (5), 430-441, 2011 | 43 | 2011 |
| Design of controlled release inert matrices of naltrexone hydrochloride based on percolation concepts I Caraballo, LM Melgoza, J Alvarez-Fuentes, MC Soriano, AM Rabasco International journal of pharmaceutics 181 (1), 23-30, 1999 | 43 | 1999 |
| Protein-loaded PLGA microparticles engineered by flow focusing: physicochemical characterization and protein detection by reversed-phase HPLC MA Holgado, MJ Cózar-Bernal, S Salas, JL Arias, J Alvarez-Fuentes, ... International Journal of Pharmaceutics 380 (1-2), 147-154, 2009 | 42 | 2009 |
| In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles MD Cayero-Otero, MJ Gomes, C Martins, J Álvarez-Fuentes, ... Expert opinion on drug delivery 16 (12), 1413-1427, 2019 | 40 | 2019 |
| Communications simultaneous HPLC determination of some drugs commonly used in cold medications: dextromethorphan, dephenhydramine, phenylephrine, phenylpropanolamine and … I Caraballo, M Fernández-Arévalo, MA Holgado, J Alvarez-Fuentes, ... Drug development and industrial pharmacy 21 (5), 605-613, 1995 | 40 | 1995 |
| Physical characterization of carteolol: Eudragit® L binding interaction MA Holgado, M Fernandez-Arevalo, J Alvarez-Fuentes, I Caraballo, ... International journal of pharmaceutics 114 (1), 13-21, 1995 | 39 | 1995 |
| Engineering of Δ9-tetrahydrocannabinol delivery systems based on surface modified-PLGA nanoplatforms L Martín-Banderas, I Munoz-Rubio, J Álvarez-Fuentes, M Durán-Lobato, ... Colloids and Surfaces B: Biointerfaces 123, 114-122, 2014 | 34 | 2014 |
| Influence of diluents and manufacturing method on the in vitro dissolution of carteolol hydrochloride matrix tablets MA Holgado, I Caraballo, J Alvarez-Fuentes, MJ Fernández-Hervás, ... International journal of pharmaceutics 118 (2), 151-160, 1995 | 32 | 1995 |
